Thoraflex™ Hybrid IDE Study

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 22, 2016

Primary Completion Date

June 24, 2019

Study Completion Date

July 30, 2021

Conditions
Aortic AneurysmAortic DissectionAortic Rupture
Interventions
DEVICE

Thoraflex™ Hybrid Device

Single-use medical device sterilized by ethylene oxide which is pre-loaded into a delivery system. The device comprises a gelatin sealed vascular graft combined with a stented graft.

Trial Locations (12)

10029

The Mount Sinai Hospital, New York

10032

Columbia University Medical Center, New York

10065

NY Presbyterian Weill Cornell, New York

10104

University of Pennsylvania, Philadelphia

15213

University of Pittsburgh Medical Center (UPMC) Presbyterian, Pittsburgh

30342

Emory Saint Joseph's Hospital, Atlanta

44195

Cleveland Clinic, Cleveland

60611

Northwestern Memorial Hospital, Chicago

77030

Baylor St. Luke's, Houston

University of Texas Houston- Memorial Hermann Texas Medical Center, Houston

94305-5407

Stanford University Medical Center, Palo Alto

48109-5853

University of Michigan, Ann Arbor

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Vascutek Ltd.

INDUSTRY

lead

Bolton Medical

INDUSTRY

NCT02724072 - Thoraflex™ Hybrid IDE Study | Biotech Hunter | Biotech Hunter